Publication | Closed Access

Prospective study of HBV reactivation risk in rheumatoid arthritis patients who received conventional disease-modifying antirheumatic drugs

Rheumatoid DisorderRheumatologyAutoimmune DiseaseHbv Reactivation RiskImmunologyHepatitisInflammatory Rheumatic DiseaseRheumatoid Arthritis PatientsProspective StudyChronic Viral InfectionMedicineRheumatoid Arthritis